Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Transfusion. 2020 Oct 18;61(1):108–123. doi: 10.1111/trf.16141

FIGURE 3.

FIGURE 3

Metabolomics analyses on stored human RBCs from two cohorts of patients who received testosterone replacement therapy (TRT) and their matched controls (no TRT). A, Top significant metabolites by ANOVA and related pathways are highlighted in the heat map for cohort 1, which consisted of five TRT patients who presented for therapeutic phlebotomy and three sex, age, and race/ethnicity-matched controls. B, Top significant metabolites by ANOVA and related pathways are highlighted in the heat map for cohort 2, which consisted of six eligible allogeneic blood donors (n = 3 TRT and n = 3 matched controls)